10-Q Filing

SOLENO THERAPEUTICS INC CIK: 1484565 Q2 2019

Filing Information

Form Type	10-Q
Accession Number	`0001564590-19-030078`
Period End Date	20190630
Filing Date	20190807
Fiscal Year	2019
Fiscal Period	Q2
XBRL Instance	slno-20190630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 54 Income Statement 62 Cash Flow Statement 54 Stockholders Equity 29

Balance Sheet 54 line items

Line Item	Tag	Value	Unit	Period
Preferred stock par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	31.79M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	31.76M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$23.10M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$15.50M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	31.79M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$471.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$529.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	31.76M	shares	Point-in-time
Due from related party	`DueFromRelatedPartiesCurrent`	$64.00K	USD	Point-in-time
Due from related party	`DueFromRelatedPartiesCurrent`	$18.00K	USD	Point-in-time
Minority interest investment in former subsidiary	`MinorityInterestInvestmentInSubsidiary`	$978.00K	USD	Point-in-time
Minority interest investment in former subsidiary	`MinorityInterestInvestmentInSubsidiary`	$623.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$16.61M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$24.67M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$12.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$22.00K	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$18.47M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$17.50M	USD	Point-in-time
Total assets	`Assets`	$34.13M	USD	Point-in-time
Total assets	`Assets`	$43.15M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.74M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$934.00K	USD	Point-in-time
Accrued compensation and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$943.00K	USD	Point-in-time
Accrued compensation and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$1.11M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.85M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.88M	USD	Point-in-time
Contingent liability for Essentialis purchase price	`AssetAcquisitionContingentConsiderationLiabilityNoncurrent`	$6.04M	USD	Point-in-time
Contingent liability for Essentialis purchase price	`AssetAcquisitionContingentConsiderationLiabilityNoncurrent`	$5.65M	USD	Point-in-time
Total liabilities	`Liabilities`	$12.74M	USD	Point-in-time
Total liabilities	`Liabilities`	$20.29M	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock	`CommonStockValue`	$32.00K	USD	Point-in-time
Common stock	`CommonStockValue`	$32.00K	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapitalCommonStock`	$157.41M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapitalCommonStock`	$157.88M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-127.03M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-144.07M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$13.84M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$26.82M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$30.41M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$23.25M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$23.63M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$16.65M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$43.15M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$34.13M	USD	Point-in-time

Income Statement 62 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$3.75M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$6.50M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.89M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.71M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$3.63M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.77M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.70M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$3.71M	USD	2 Qtrs
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$361.00K	USD	2 Qtrs
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$-67.00K	USD	1 Quarter
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$183.00K	USD	1 Quarter
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$389.00K	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$5.62M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$10.60M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$6.89M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$3.41M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-3.41M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-5.62M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-10.60M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-6.89M	USD	2 Qtrs
Cease-use income	`GainLossOnContractTermination`	$6.00K	USD	2 Qtrs
Cease-use income	`GainLossOnContractTermination`	$3.00K	USD	1 Quarter
Change in fair value of warrants liabilities	`FairValueAdjustmentOfWarrants`	$4.27M	USD	1 Quarter
Change in fair value of warrants liabilities	`FairValueAdjustmentOfWarrants`	$6.19M	USD	2 Qtrs
Change in fair value of warrants liabilities	`FairValueAdjustmentOfWarrants`	$3.25M	USD	1 Quarter
Change in fair value of warrants liabilities	`FairValueAdjustmentOfWarrants`	$3.09M	USD	2 Qtrs
Loss from minority interest investment	`IncomeLossFromMinorityInterestInvestments`	$-355.00K	USD	2 Qtrs
Loss from minority interest investment	`IncomeLossFromMinorityInterestInvestments`	$-165.00K	USD	1 Quarter
Interest income	`OtherNonoperatingIncomeExpense`	$104.00K	USD	2 Qtrs
Interest income	`OtherNonoperatingIncomeExpense`	$30.00K	USD	1 Quarter
Interest income	`OtherNonoperatingIncomeExpense`	$49.00K	USD	2 Qtrs
Interest income	`OtherNonoperatingIncomeExpense`	$47.00K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-3.22M	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-4.38M	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-6.44M	USD	2 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$-3.04M	USD	2 Qtrs
Loss from continuing operations	`IncomeLossFromContinuingOperations`	$-10.01M	USD	1 Quarter
Loss from continuing operations	`IncomeLossFromContinuingOperations`	$-9.93M	USD	2 Qtrs
Loss from continuing operations	`IncomeLossFromContinuingOperations`	$-6.63M	USD	1 Quarter
Loss from continuing operations	`IncomeLossFromContinuingOperations`	$-17.04M	USD	2 Qtrs
Loss from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-423.00K	USD	1 Quarter
Loss from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-937.00K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-7.03M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-17.04M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-7.06M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-10.86M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-3.80M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-10.01M	USD	1 Quarter
Loss per common share from continuing operations, basic and diluted	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.31	USD	1 Quarter
Loss per common share from continuing operations, basic and diluted	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.50	USD	2 Qtrs
Loss per common share from continuing operations, basic and diluted	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.54	USD	2 Qtrs
Loss per common share from continuing operations, basic and diluted	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.33	USD	1 Quarter
Loss per common share from discontinued operations, basic and diluted	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare`	$-0.02	USD	1 Quarter
Loss per common share from discontinued operations, basic and diluted	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare`	$-0.05	USD	2 Qtrs
Net loss per common share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.54	USD	2 Qtrs
Net loss per common share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.31	USD	1 Quarter
Net loss per common share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.55	USD	2 Qtrs
Net loss per common share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.35	USD	1 Quarter
Weighted-average common shares outstanding used to calculate basic and diluted net loss per common share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	20.35M	shares	1 Quarter
Weighted-average common shares outstanding used to calculate basic and diluted net loss per common share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	19.94M	shares	2 Qtrs
Weighted-average common shares outstanding used to calculate basic and diluted net loss per common share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	31.78M	shares	1 Quarter
Weighted-average common shares outstanding used to calculate basic and diluted net loss per common share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	31.77M	shares	2 Qtrs

Cash Flow Statement 54 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-17.04M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-10.86M	USD	2 Qtrs
Loss from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-423.00K	USD	1 Quarter
Loss from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-937.00K	USD	2 Qtrs
Loss from continuing operations	`IncomeLossFromContinuingOperations`	$-10.01M	USD	1 Quarter
Loss from continuing operations	`IncomeLossFromContinuingOperations`	$-9.93M	USD	2 Qtrs
Loss from continuing operations	`IncomeLossFromContinuingOperations`	$-6.63M	USD	1 Quarter
Loss from continuing operations	`IncomeLossFromContinuingOperations`	$-17.04M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$978.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$983.00K	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$519.00K	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$377.00K	USD	2 Qtrs
Board fees paid with common stock	`OtherNoncashExpense`	$91.00K	USD	2 Qtrs
Board fees paid with common stock	`OtherNoncashExpense`	$136.00K	USD	2 Qtrs
Change in fair value of stock warrants	`FairValueAdjustmentOfWarrants`	$4.27M	USD	1 Quarter
Change in fair value of stock warrants	`FairValueAdjustmentOfWarrants`	$6.19M	USD	2 Qtrs
Change in fair value of stock warrants	`FairValueAdjustmentOfWarrants`	$3.25M	USD	1 Quarter
Change in fair value of stock warrants	`FairValueAdjustmentOfWarrants`	$3.09M	USD	2 Qtrs
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$361.00K	USD	2 Qtrs
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$-67.00K	USD	1 Quarter
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$183.00K	USD	1 Quarter
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$389.00K	USD	2 Qtrs
Operating loss on minority interest investment	`IncomeLossFromEquityMethodInvestments`	$-355.00K	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-95.00K	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-58.00K	USD	2 Qtrs
Due from related party	`IncreaseDecreaseInDueFromRelatedParties`	$-46.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$806.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$348.00K	USD	2 Qtrs
Accrued compensation and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$172.00K	USD	2 Qtrs
Accrued compensation and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-111.00K	USD	2 Qtrs
Net cash used in continuing operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-7.58M	USD	2 Qtrs
Net cash used in continuing operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-4.50M	USD	2 Qtrs
Net cash used in discontinued operating activities	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-768.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-5.27M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-7.58M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.00K	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$16.00K	USD	2 Qtrs
Net cash used in continuing investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-16.00K	USD	2 Qtrs
Net cash used in continuing investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-1.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-16.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.00K	USD	2 Qtrs
Net cash provided by discontinued financing activities	`CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations`	$825.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$825.00K	USD	2 Qtrs
Net decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-4.45M	USD	2 Qtrs
Net decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-7.60M	USD	2 Qtrs
Net increase in cash and cash equivalents included in current assets held for sale	`CashAndCashEquivalentsPeriodIncreaseDecreaseIncludedInCurrentAssetsHeldForSale`	$-96.00K	USD	2 Qtrs
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$15.50M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$12.59M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$23.10M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$17.14M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$15.50M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$12.59M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$23.10M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$17.14M	USD	Point-in-time

Stockholders Equity 29 line items

Line Item	Tag	Value	Unit	Period
Balances at beginning	`StockholdersEquity`	$13.84M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$26.82M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$30.41M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$23.25M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$23.63M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$16.65M	USD	Point-in-time
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$199.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$202.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$175.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$200.00K	USD	1 Quarter
Issuance of common stock on conversion of series B convertible preferred shares	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$1.00K	USD	1 Quarter
Issuance of common stock on conversion of series B convertible preferred shares	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$-1.00K	USD	1 Quarter
Issuance of restricted common stock for bonuses	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	$159.00K	USD	1 Quarter
Issuance of common stock to board members in lieu of cash payments for quarterly board fees	`StockIssuedDuringPeriodValueIssuedForServices`	$45.00K	USD	1 Quarter
Issuance of common stock to board members in lieu of cash payments for quarterly board fees	`StockIssuedDuringPeriodValueIssuedForServices`	$46.00K	USD	1 Quarter
Issuance of common stock to board members in lieu of cash payments for quarterly board fees	`StockIssuedDuringPeriodValueIssuedForServices`	$82.00K	USD	1 Quarter
Issuance of common stock to board members in lieu of cash payments for quarterly board fees	`StockIssuedDuringPeriodValueIssuedForServices`	$54.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.03M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-17.04M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-7.06M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-10.86M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-3.80M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-10.01M	USD	1 Quarter
Balances at ending	`StockholdersEquity`	$13.84M	USD	Point-in-time
Balances at ending	`StockholdersEquity`	$26.82M	USD	Point-in-time
Balances at ending	`StockholdersEquity`	$30.41M	USD	Point-in-time
Balances at ending	`StockholdersEquity`	$23.25M	USD	Point-in-time
Balances at ending	`StockholdersEquity`	$23.63M	USD	Point-in-time
Balances at ending	`StockholdersEquity`	$16.65M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.